אודות פרק זה

אנגלית
ארצות הברית

תעתיק 🔗

חיפוש פרקים ישנים

חפש פרקים קודמים של PharmaSource Podcast.

פרקים אחרים בפודקאסט הזה

At CDMO Live Europe 2026, Dr. Olivier Aebischer, Deputy CEO at Interlabor Belp AG, demonstrated how a structured, dual-path analytical approach can identify manufacturing root causes in days, using two real contamination case studies from the lab’s operations.
“There isn’t enough capacity for antibody-oligo conjugates out there today, full stop,” says Geoff Glass, CEO of Abzena. “And it’s really because of the volume requirements for the diseases.” Geoff Glass is Chief Executive Officer of Abzena, the end-to-end, fully integrated CDMO and CRO for comple‮…
“Rather than saying that there’s a gap from the industry, I think there’s a listening gap from our governments.” Neha Dave is an independent EU Government Affairs Advisor based in Brussels, with more than 20 years of experience across the EU institutions, agency-side consulting at Weber Shandwick,‮…
“We can adjust and be flexible around equipment configuration, but we can’t be flexible around what is a clear communicator and an honest partner.” Damien Perriman is Chief Commercial Officer at ExoZymes, a Nasdaq-listed company using AI-enhanced enzymes to produce pharmaceutical and nutraceutical‮…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Life Science Networks, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.